Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer in the United States and the United Kingdom. The company's proprietary oncolytic im...
Leadership
Sushil Patel Ph.D.
CEO & Director
Emily Luisa Hill
Chief Financial Officer
Konstantinos Xynos M.B.A., M.D., Ph.D.
Chief Medical Officer
Philip Astley-Sparke F.S.A.
Executive Chairman
Andrew Schwendenman
Chief Accounting Officer & Treasurer
Shawn Glidden J.D.
Senior VP & General Counsel
Camilo Garcia M.A., M.B.A.
Chief Human Resource Officer
Paul Bullock
Chief Manufacturing Officer & Framingham Site Head
Nina Aragam
Senior Vice President of Portfolio Strategy & Program Management
